Cell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) :

Affiliation auteurs!!!! Error affiliation !!!!
TitreCell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) :
Type de publicationJournal Article
Year of Publication2015
AuteursLaboure G, Parrens M-C, Tsaranazy A, Bordier M, Le Gouill S, Delwail V, Gressin R, Cornillon J, Damaj G, Foussard CYves, Maisonneuve H, Deconinck E, Cartron G, Dreyfus F, Gyan E, Sutton L, Morineau N, Alexis M, Banos A, Damotte D, Moreau A, Kraeber-Bodere F, Rossille D, Fest T, Lamy T, Milpied N
JournalBLOOD
Volume126
Date PublishedDEC 3
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood.V126.23.3920.3920